CVS Health, Cigna and UnitedHealth Group sued the Federal Trade Commission on Tuesday, alleging that the administrative process the Lina Khan-led agency is using to prosecute claims that their pharmacy benefit manager subsidiaries artificially inflated insulin prices violates their constitutional rights.